Inventor · disambiguated record
Lars Otto Uttenthal
Also filed as: UTTENTHAL LARS · UTTENTHAL LARS OTTO
15 granted patents·32 pending applications·35 citations·filing 2002–2021
88Inventor score
Files withANTIBODYSHOP AS10REPOCEUTICALS APS6REPONEX PHARMACEUTICALS AS6Reponex Pharmaceuticals Aps6REPOCEUTICALS AS5
Top patents by PatentIndex Score
47 records- 0181US8461115B2Methods for local treatment with factor VIIUTTENTHAL LARS OTTO·Filed 2007·Granted Jun 11, 2013·7 cites·24 claims
- 0281US7211396B2Antibody pairs and kits for immunochemical determination of mannan-binding lectinANTIBODYSHOP AS·Filed 2002·Granted May 1, 2007·24 cites·7 claims
- 0372US9927446B2Methods and devices for rapid assessment of severity of injuryANTIBODYSHOP AS·Filed 2015·Granted Mar 27, 2018·1 cites·7 claims
- 0465US12239727B2Compositions for use in the treatment of photosensitivityREPOCEUTICALS AS·Filed 2019·Granted Mar 4, 2025·0 cites·8 claims
- 0565US2019170770A1Diagnostic Test to Exclude Significant Renal InjuryANTIBODYSHOP AS·Filed 2019·Application pending·0 cites
- 0664US11125761B2Methods and devices for rapid assessment of severity of injuryANTIBODYSHOP AS·Filed 2018·Granted Sep 21, 2021·0 cites·9 claims
- 0764US7807639B2Methods for preventing and treating local tracheal, bronchial or alveolar bleeding or hemoptysisPHARMAORIGIN ASP·Filed 2006·Granted Oct 5, 2010·1 cites·17 claims
- 0863US8313919B2Diagnostic test for renal injuryUTTENTHAL LARS OTTO·Filed 2008·Granted Nov 20, 2012·2 cites·20 claims
- 0962US11903925B2Compositions for preventing and treating pulmonary injury due to ionizing radiation or cytotoxic drugsREPOCEUTICALS AS·Filed 2018·Granted Feb 20, 2024·0 cites·8 claims
- 1061US2022218792A1Compositions to promote the healing of skin ulcers and woundsREPONEX PHARMACEUTICALS AS·Filed 2021·Application pending·0 cites
- 1160US2015064730A1Methods and Devices for Rapid Assessment of Severity of InjuryANTIBODYSHOP AS·Filed 2014·Application pending·0 cites
- 1259US10716831B2Methods for inhibiting infectious peritonitisReponex Pharmaceuticals Aps·Filed 2018·Granted Jul 21, 2020·0 cites·17 claims
- 1359US2021267942A1Melatonin for preventing and treating radiation vaginitis and proctitisREPOCEUTICALS APS·Filed 2020·Application pending·0 cites
- 1458US2022168425A1Compositions for retarding the decomposition of melatonin in solutionREPOCEUTICALS AS·Filed 2021·Application pending·0 cites
- 1556US12396980B2Melatonin for preventing and treating radiation cystitisREPOCEUTICALS AS·Filed 2019·Granted Aug 26, 2025·0 cites·11 claims
- 1656US2016109463A1Methods for Safe Administration of Nephrotoxic AgentsANTIBODYSHOP AS·Filed 2015·Application pending·0 cites
- 1756US2021121528A1Compositions for treating lung infections by airway administrationReponex Pharmaceuticals Aps·Filed 2020·Application pending·0 cites
- 1855US2013137124A1Diagnostic test to exclude significant renal injuryANTIBODYSHOP AS·Filed 2013·Application pending·0 cites
- 1953US11471445B2Compositions for the prevention and treatment of acute renal injuryAKI THERAPEUTICS APS·Filed 2018·Granted Oct 18, 2022·0 cites·7 claims
- 2053US2010304413A1Diagnostic use of individual molecular forms of a biomarkerUTTENTHAL LARS OTTO·Filed 2008·Application pending·0 cites
- 2153US2016003851A1Treatment of Acute Tubular Necrosis or Acute Tubule-Interstitial NephropathyANTIBODYSHOP AS·Filed 2015·Application pending·0 cites
- 2253US2010210031A2Diagnostic Test to Exclude Significant Renal InjuryANTIBODYSHOP AS·Filed 2007·Application pending·0 cites
- 2352US2015132772A1Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal DisordersANTIBODYSHOP AS·Filed 2015·Application pending·0 cites
- 2451US2020254062A1Compositions to promote the healing of skin ulcers and woundsREPONEX PHARMACEUTICALS AS·Filed 2019·Application pending·0 cites
- 2551US2020030450A1Compositions for retarding the decomposition of melatonin in solutionREPOCEUTICALS APS·Filed 2018·Application pending·0 cites
- 2650US2013177923A1Diagnostic use of individual molecular forms of a biomarkerBIOPORTO DIAGNOSTICS AS·Filed 2013·Application pending·0 cites
- 2749US8088728B2Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tractUTTENTHAL LARS OTTO·Filed 2006·Granted Jan 3, 2012·0 cites·13 claims
- 2848US8431535B2Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysisHESLET LARS·Filed 2005·Granted Apr 30, 2013·0 cites·14 claims
- 2948US2018289773A1Compositions for treating lung infections by airway administrationReponex Pharmaceuticals Aps·Filed 2018·Application pending·0 cites
- 3048US2003129661A1Compositions, methods and kits for detection and quantification of plant and animal source contaminantsFiled 2002·Application pending·0 cites
- 3147US2009170143A1Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal DisordersUTTENTHAL LARS OTTO·Filed 2005·Application pending·0 cites
- 3246US2009197280A1Methods and Devices for Rapid Assessment of Severity of InjuryBANGERT KRISTIAN·Filed 2007·Application pending·0 cites
- 3344US2024033342A1Compositions for treating gastrointestinal adenocarcinomas by altering the tumor microenvironmentNORDIC SCIENCE GROUP APS·Filed 2021·Application pending·0 cites
- 3442US2018050019A1Melatonin for Preventing and Treating Radiation Vaginitis and ProctitisREPOCEUTICALS APS·Filed 2016·Application pending·0 cites
- 3542US2018000781A1Compositions for Preventing and Treating Pulmonary Injury due to Ionizing Radiation or Cytotoxic DrugsREPOCEUTICALS APS·Filed 2016·Application pending·0 cites
- 3641US2023057930A1Compositions for alleviating the symptoms of low anterior resection syndrome by topical administration to the neorectumREPOCEUTICALS AS·Filed 2021·Application pending·0 cites
- 3740US8101366B2Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an anti-inflammatory and/or anticoagulatory agentBANGERT KRISTIAN·Filed 2007·Granted Jan 24, 2012·0 cites·19 claims
- 3838US2016346354A1Compositions to promote the healing of skin ulcers and woundsReponex Pharmaceuticals Aps·Filed 2015·Application pending·0 cites
- 3938US2017035850A1Compositions for treating lung infections by airway administrationReponex Pharmaceuticals Aps·Filed 2015·Application pending·0 cites
- 4036US2018200208A1Compositions for improving or maintaining myocardial functionREPOCEUTICALS APS·Filed 2016·Application pending·0 cites
- 4136US2022175885A1Targeting biological agents to mucosal defects of the gastrointestinal tractREPONEX PHARMACEUTICALS AS·Filed 2020·Application pending·0 cites
- 4236US2021060038A1Compositions for eliminating bacterial promotors of colorectal cancer by intraluminal applicationREPONEX PHARMACEUTICALS AS·Filed 2019·Application pending·0 cites
- 4334US10105415B2Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel diseaseREPONEX PHARMACEUTICALS AS·Filed 2015·Granted Oct 23, 2018·0 cites·10 claims
- 4434US2022211667A1Composition for the intraperitoneal treatment of secondary bacterial peritonitis with reduction of complicationsREPONEX PHARMACEUTICALS AS·Filed 2020·Application pending·0 cites
- 4534US2017232069A1Compositions for the treatment of peritonitisReponex Pharmaceuticals Aps·Filed 2015·Application pending·0 cites
- 4633US2003170230A1Compositions and methods for assembly and stabilization of antibody Fv fragments via antiparallel heterogeneous coiled-coil peptide regions and uses thereofFiled 2003·Application pending·0 cites
- 4731US2018055822A1Melatonin for Preventing and Treating Radiation CystitisREPOCEUTICALS APS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Otto Uttenthal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →